Biosurgery Market Size, Share, Trends, Industry Analysis Report By Product (Surgical Sealants, Hemostatic Agents, Adhesion Barriers, Soft Tissue Attachments, Bone Graft Attachments, Others), By Application, By Region

Description

List of Tables

The biosurgery market size is expected to reach USD 41.00 billion by 2034, according to a new study by Polaris Market Research. The report "Biosurgery Market Share, Size, Trends, Industry Analysis Report By Product (Surgical Sealants, Hemostatic Agents, Adhesion Barriers, Soft Tissue Attachments, Bone Graft Attachments, Others), By Application, By Region; Market Forecast, 2025-2034" gives a detailed insight into current market dynamics and provides analysis on future market growth.

Biosurgery is a specialized medical field that utilizes natural biological organisms or substances to support surgical procedures, thereby promoting healing and minimizing complications. Surgeons employ maggot debridement, leeches, enzymes, or other biological agents to treat wounds, remove dead tissue, or improve blood flow. These methods offer a minimally invasive alternative to traditional surgery, benefiting patients who cannot undergo conventional procedures due to health risks.

Biosurgery offers several advantages, including lower infection rates, reduced scarring, and faster recovery times compared to conventional surgery. It also benefits patients with compromised immune systems or those at high risk for anesthesia complications. However, practitioners must carefully select candidates, as some individuals may experience allergic reactions or psychological discomfort with certain biological agents.

Biosurgery Market Report Highlights

In terms of product, the surgical sealants segment accounted for 28.38% revenue share in 2024 due to their increasing use across a wide range of surgical specialties, including cardiovascular, pulmonary, and hepatic procedures.

The soft tissue attachments segment, based on product, is projected to grow at a robust pace in the coming years, owing to the surge in the number of sports injury cases, orthopedic reconstructions, and soft tissue repair procedures.

Based on application, the general surgery dominated the revenue market share in 2024 due to the rising penetration of abdominal, gastrointestinal, and hepatobiliary procedures that require effective bleeding control and tissue sealing.

The cardiovascular surgery segment, in terms of application, is projected to grow at a rapid pace in the coming years, driven by the increasing prevalence of heart diseases and the rising number of open-heart and vascular procedures.

North America accounted for 51.16% share of the global biosurgery market in 2024. This dominance is attributed to the growing prevalence of chronic diseases and an aging population.

The U.S. held 77.79% of the North America biosurgery market share in 2024 due to high healthcare spending and a strong focus on minimally invasive procedures.

The market in Asia Pacific is projected to grow at a robust pace in the coming years, owing to the rapidly improving healthcare infrastructure and increasing surgical procedures.

The market in India is expanding due to rising awareness of advanced wound care and surgical hemostats.

The market in Europe is projected to hold a substantial market share in 2034 due to established healthcare systems and high surgical volumes.

A few global key market players include Artivion, Inc.; Aroa Biosurgery; B. Braun SE; Baxter; BD; INTEGRA LIFESCIENCES; Johnson & Johnson Services, Inc.; Medtronic; Pfizer Inc.; Sanofi; and Stryker.

Polaris Market Research has segmented the biosurgery market report on the basis of product, application, and region:

By Product Outlook (Revenue, USD Billion, 2020-2034)

Surgical Sealants

Hemostatic Agents

Adhesion Barriers

Soft Tissue Attachments

Bone Graft Attachments

Others

By Application Outlook (Revenue, USD Billion, 2020-2034)

General Surgery

Orthopedic Surgery

Cardiovascular Surgery

Neurological Surgery

Others

By Regional Outlook (Revenue, USD Billion, 2020-2034)

North America

U.S.

Canada

Europe

Germany

France

Italy

Spain

Netherlands

Russia

Rest of Europe

Asia Pacific

China

Japan

India

Malaysia

South Korea

Indonesia

Australia

Vietnam

Rest of Asia Pacific

Middle East & Africa

Saudi Arabia

UAE

Israel

South Africa

Rest of Middle East & Africa

Latin America

Mexico

Brazil

Argentina

Rest of Latin America

Product Code: PM5930

1. Introduction

1.1. Report Description
- 1.1.1. Objectives of the Study
- 1.1.2. Market Scope
- 1.1.3. Assumptions
1.2. Stakeholders

2. Executive Summary

2.1. Market Highlights

3. Research Methodology

3.1. Overview
- 3.1.1. Data Mining
3.2. Data Sources
- 3.2.1. Primary Sources
- 3.2.2. Secondary Sources

4. Global Biosurgery Market Insights

4.1. Biosurgery Market - Market Snapshot
4.2. Biosurgery Market Dynamics
- 4.2.1. Drivers and Opportunities
  - 4.2.1.1. Increasing Demand for Minimally Invasive Surgical Procedures
  - 4.2.1.2. Growing Prevalence of Chronic Diseases
- 4.2.2. Restraints and Challenges
  - 4.2.2.1. High cost
4.3. Porter's Five Forces Analysis
- 4.3.1. Bargaining Power of Suppliers (Moderate)
- 4.3.2. Threats of New Entrants: (Low)
- 4.3.3. Bargaining Power of Buyers (Moderate)
- 4.3.4. Threat of Substitute (Moderate)
- 4.3.5. Rivalry among existing firms (High)
4.4. PESTEL Analysis
4.5. Biosurgery Market Trends
4.6. Value Chain Analysis
4.7. COVID-19 Impact Analysis

5. Global Biosurgery Market, by Product

5.1. Key Findings
5.2. Introduction
- 5.2.1. Global Biosurgery Market, by Product, 2020-2034 (USD Billion)
5.3. Surgical Sealants
- 5.3.1. Global Biosurgery Market, by Surgical Sealants, by Region, 2020-2034 (USD Billion)
5.4. Hemostatic Agents
- 5.4.1. Global Biosurgery Market, by Hemostatic Agents, by Region, 2020-2034 (USD Billion)
5.5. Adhesion Barriers
- 5.5.1. Global Biosurgery Market, by Adhesion Barriers, by Region, 2020-2034 (USD Billion)
5.6. Soft Tissue Attachments
- 5.6.1. Global Biosurgery Market, by Soft Tissue Attachments, by Region, 2020-2034 (USD Billion)
5.7. Bone Graft Attachments
- 5.7.1. Global Biosurgery Market, by Bone Graft Attachments, by Region, 2020-2034 (USD Billion)
5.8. Others
- 5.8.1. Global Biosurgery Market, by Others, by Region, 2020-2034 (USD Billion)

6. Global Biosurgery Market, by Application

6.1. Key Findings
6.2. Introduction
- 6.2.1. Global Biosurgery Market, by Application, 2020-2034 (USD Billion)
6.3. General Surgery
- 6.3.1. Global Biosurgery Market, by General Surgery, by Region, 2020-2034 (USD Billion)
6.4. Orthopedic Surgery
- 6.4.1. Global Biosurgery Market, by Orthopedic Surgery, by Region, 2020-2034 (USD Billion)
6.5. Cardiovascular Surgery
- 6.5.1. Global Biosurgery Market, by Cardiovascular Surgery, by Region, 2020-2034 (USD Billion)
6.6. Neurological Surgery
- 6.6.1. Global Biosurgery Market, by Neurological Surgery, by Region, 2020-2034 (USD Billion)
6.7. Others
- 6.7.1. Global Biosurgery Market, by Others, by Region, 2020-2034 (USD Billion)

7. Global Biosurgery Market, by Geography

7.1. Key Findings
7.2. Introduction
- 7.2.1. Biosurgery Market Assessment, By Geography, 2020-2034 (USD Billion)
7.3. Biosurgery Market - North America
- 7.3.1. North America: Biosurgery Market, by Product, 2020-2034 (USD Billion)
- 7.3.2. North America: Biosurgery Market, by Application, 2020-2034 (USD Billion)
- 7.3.3. Biosurgery Market - U.S.
  - 7.3.3.1. U.S.: Biosurgery Market, by Product, 2020-2034 (USD Billion)
  - 7.3.3.2. U.S.: Biosurgery Market, by Application, 2020-2034 (USD Billion)
- 7.3.4. Biosurgery Market - Canada
  - 7.3.4.1. Canada: Biosurgery Market, by Product, 2020-2034 (USD Billion)
  - 7.3.4.2. Canada: Biosurgery Market, by Application, 2020-2034 (USD Billion)
7.4. Biosurgery Market - Europe
- 7.4.1. Europe: Biosurgery Market, by Product, 2020-2034 (USD Billion)
- 7.4.2. Europe: Biosurgery Market, by Application, 2020-2034 (USD Billion)
- 7.4.3. Biosurgery Market - UK
  - 7.4.3.1. UK: Biosurgery Market, by Product, 2020-2034 (USD Billion)
  - 7.4.3.2. UK: Biosurgery Market, by Application, 2020-2034 (USD Billion)
- 7.4.4. Biosurgery Market - France
  - 7.4.4.1. France: Biosurgery Market, by Product, 2020-2034 (USD Billion)
  - 7.4.4.2. France: Biosurgery Market, by Application, 2020-2034 (USD Billion)
- 7.4.5. Biosurgery Market - Germany
  - 7.4.5.1. Germany: Biosurgery Market, by Product, 2020-2034 (USD Billion)
  - 7.4.5.2. Germany: Biosurgery Market, by Application, 2020-2034 (USD Billion)
- 7.4.6. Biosurgery Market - Italy
  - 7.4.6.1. Italy: Biosurgery Market, by Product, 2020-2034 (USD Billion)
  - 7.4.6.2. Italy: Biosurgery Market, by Application, 2020-2034 (USD Billion)
- 7.4.7. Biosurgery Market - Spain
  - 7.4.7.1. Spain: Biosurgery Market, by Product, 2020-2034 (USD Billion)
  - 7.4.7.2. Spain: Biosurgery Market, by Application, 2020-2034 (USD Billion)
- 7.4.8. Biosurgery Market - Netherlands
  - 7.4.8.1. Netherlands: Biosurgery Market, by Product, 2020-2034 (USD Billion)
  - 7.4.8.2. Netherlands: Biosurgery Market, by Application, 2020-2034 (USD Billion)
- 7.4.9. Biosurgery Market - Russia
  - 7.4.9.1. Russia: Biosurgery Market, by Product, 2020-2034 (USD Billion)
  - 7.4.9.2. Russia: Biosurgery Market, by Application, 2020-2034 (USD Billion)
- 7.4.10. Biosurgery Market - Rest of Europe
  - 7.4.10.1. Rest of Europe: Biosurgery Market, by Product, 2020-2034 (USD Billion)
  - 7.4.10.2. Rest of Europe: Biosurgery Market, by Application, 2020-2034 (USD Billion)
7.5. Biosurgery Market - Asia Pacific
- 7.5.1. Asia Pacific: Biosurgery Market, by Product, 2020-2034 (USD Billion)
- 7.5.2. Asia Pacific: Biosurgery Market, by Application, 2020-2034 (USD Billion)
- 7.5.3. Biosurgery Market - China
  - 7.5.3.1. China: Biosurgery Market, by Product, 2020-2034 (USD Billion)
  - 7.5.3.2. China: Biosurgery Market, by Application, 2020-2034 (USD Billion)
- 7.5.4. Biosurgery Market - India
  - 7.5.4.1. India: Biosurgery Market, by Product, 2020-2034 (USD Billion)
  - 7.5.4.2. India: Biosurgery Market, by Application, 2020-2034 (USD Billion)
- 7.5.5. Biosurgery Market - Malaysia
  - 7.5.5.1. Malaysia: Biosurgery Market, by Product, 2020-2034 (USD Billion)
  - 7.5.5.2. Malaysia: Biosurgery Market, by Application, 2020-2034 (USD Billion)
- 7.5.6. Biosurgery Market - Japan
  - 7.5.6.1. Japan: Biosurgery Market, by Product, 2020-2034 (USD Billion)
  - 7.5.6.2. Japan: Biosurgery Market, by Application, 2020-2034 (USD Billion)
- 7.5.7. Biosurgery Market - Indonesia
  - 7.5.7.1. Indonesia: Biosurgery Market, by Product, 2020-2034 (USD Billion)
  - 7.5.7.2. Indonesia: Biosurgery Market, by Application, 2020-2034 (USD Billion)
- 7.5.8. Biosurgery Market - South Korea
  - 7.5.8.1. South Korea: Biosurgery Market, by Product, 2020-2034 (USD Billion)
  - 7.5.8.2. South Korea: Biosurgery Market, by Application, 2020-2034 (USD Billion)
- 7.5.9. Biosurgery Market - Australia
  - 7.5.9.1. Australia: Biosurgery Market, by Product, 2020-2034 (USD Billion)
  - 7.5.9.2. Australia: Biosurgery Market, by Application, 2020-2034 (USD Billion)
- 7.5.10. Biosurgery Market - Rest of Asia Pacific
  - 7.5.10.1. Rest of Asia Pacific: Biosurgery Market, by Product, 2020-2034 (USD Billion)
  - 7.5.10.2. Rest of Asia Pacific: Biosurgery Market, by Application, 2020-2034 (USD Billion)
7.6. Biosurgery Market - Middle East & Africa
- 7.6.1. Middle East & Africa: Biosurgery Market, by Product, 2020-2034 (USD Billion)
- 7.6.2. Middle East & Africa: Biosurgery Market, by Application, 2020-2034 (USD Billion)
- 7.6.3. Biosurgery Market - Saudi Arabia
  - 7.6.3.1. Saudi Arabia: Biosurgery Market, by Product, 2020-2034 (USD Billion)
  - 7.6.3.2. Saudi Arabia: Biosurgery Market, by Application, 2020-2034 (USD Billion)
- 7.6.4. Biosurgery Market - UAE
  - 7.6.4.1. UAE: Biosurgery Market, by Product, 2020-2034 (USD Billion)
  - 7.6.4.2. UAE: Biosurgery Market, by Application, 2020-2034 (USD Billion)
- 7.6.5. Biosurgery Market - Israel
  - 7.6.5.1. Israel: Biosurgery Market, by Product, 2020-2034 (USD Billion)
  - 7.6.5.2. Israel: Biosurgery Market, by Application, 2020-2034 (USD Billion)
- 7.6.6. Biosurgery Market - South Africa
  - 7.6.6.1. South Africa: Biosurgery Market, by Product, 2020-2034 (USD Billion)
  - 7.6.6.2. South Africa: Biosurgery Market, by Application, 2020-2034 (USD Billion)
- 7.6.7. Biosurgery Market - Rest of Middle East & Africa
  - 7.6.7.1. Rest of Middle East & Africa: Biosurgery Market, by Product, 2020-2034 (USD Billion)
  - 7.6.7.2. Rest of Middle East & Africa: Biosurgery Market, by Application, 2020-2034 (USD Billion)
7.7. Biosurgery Market - Latin America
- 7.7.1. Latin America: Biosurgery Market, by Product, 2020-2034 (USD Billion)
- 7.7.2. Latin America: Biosurgery Market, by Application, 2020-2034 (USD Billion)
- 7.7.3. Biosurgery Market - Mexico
  - 7.7.3.1. Mexico: Biosurgery Market, by Product, 2020-2034 (USD Billion)
  - 7.7.3.2. Mexico: Biosurgery Market, by Application, 2020-2034 (USD Billion)
- 7.7.4. Biosurgery Market - Brazil
  - 7.7.4.1. Brazil: Biosurgery Market, by Product, 2020-2034 (USD Billion)
  - 7.7.4.2. Brazil: Biosurgery Market, by Application, 2020-2034 (USD Billion)
- 7.7.5. Biosurgery Market - Argentina
  - 7.7.5.1. Argentina: Biosurgery Market, by Product, 2020-2034 (USD Billion)
  - 7.7.5.2. Argentina: Biosurgery Market, by Application, 2020-2034 (USD Billion)
- 7.7.6. Biosurgery Market - Rest of Latin America
  - 7.7.6.1. Rest of Latin America: Biosurgery Market, by Product, 2020-2034 (USD Billion)
  - 7.7.6.2. Rest of Latin America: Biosurgery Market, by Application, 2020-2034 (USD Billion)

8. Competitive Landscape

8.1. Expansion and Acquisition Analysis
- 8.1.1. Expansion
- 8.1.2. Acquisitions
8.2. Partnerships/Collaborations/Agreements/Exhibitions

9. Company Profiles

9.1. Artivion, Inc.
- 9.1.1. Company Overview
- 9.1.2. Financial Performance
- 9.1.3. Product Benchmarking
- 9.1.4. Recent Development
9.2. Aroa Biosurgery
- 9.2.1. Company Overview
- 9.2.2. Financial Performance
- 9.2.3. Product Benchmarking
- 9.2.4. Recent Development
9.3. B. Braun SE
- 9.3.1. Company Overview
- 9.3.2. Financial Performance
- 9.3.3. Product Benchmarking
- 9.3.4. Recent Development
9.4. Baxter
- 9.4.1. Company Overview
- 9.4.2. Financial Performance
- 9.4.3. Product Benchmarking
- 9.4.4. Recent Development
9.5. BD
- 9.5.1. Company Overview
- 9.5.2. Financial Performance
- 9.5.3. Product Benchmarking
- 9.5.4. Recent Development
9.6. INTEGRA LIFESCIENCES
- 9.6.1. Company Overview
- 9.6.2. Financial Performance
- 9.6.3. Product Benchmarking
- 9.6.4. Recent Development
9.7. Johnson & Johnson Services, Inc.
- 9.7.1. Company Overview
- 9.7.2. Financial Performance
- 9.7.3. Product Benchmarking
- 9.7.4. Recent Development
9.8. Medtronic
- 9.8.1. Company Overview
- 9.8.2. Financial Performance
- 9.8.3. Product Benchmarking
- 9.8.4. Recent Development
9.9. Sanofi
- 9.9.1. Company Overview
- 9.9.2. Financial Performance
- 9.9.3. Product Benchmarking
- 9.9.4. Recent Development
9.10. Pfizer Inc.
- 9.10.1. Company Overview
- 9.10.2. Financial Performance
- 9.10.3. Product Benchmarking
- 9.10.4. Recent Development
9.11. Stryker
- 9.11.1. Company Overview
- 9.11.2. Financial Performance
- 9.11.3. Product Benchmarking
- 9.11.4. Recent Development